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Abstract
Background: Both mechanical and phased-array catheters are used in clinical trials to assess quantitative
parameters. Only limited evaluation of the in vivo agreement of volumetrical measurements between such
systems has been performed, despite the fact that such information is essential for the conduction of
atherosclerosis regression trials. Methods and results: We prospectively evaluated the agreement in mor-
phometric measurements and intravascular ultrasound (IVUS)-based plaque characterization between a
40 MHz rotating transducer (3.2 F Atlantis, Boston Scientific Corp.) and a 20 MHz phased-array catheter
(2.9 F Eagle Eye, Volcano Therapeutics, Rancho Cordova, California) in 16 patients. Lumen
(7.3 ± 2.0 mm2 vs. 6.7 ± 1.8 mm2, p = 0.001) and vessel (11.8 ± 3.3 mm2 vs. 11.0 ± 2.9 mm2,
p = 0.02) cross-sectional areas (CSA) were significantly greater with the 20 MHz system. Plaque CSA
measurements showed no significant difference between systems (4.4 ± 2.3 mm2 vs. 4.4 ± 2.1). The rel-
ative differences were less than 10% for the three variables. On IVUS-based tissue characterization (13
patients), calculated percentage hypoechogenic volume was significantly higher for the 20 MHz system
(96.7 ± 2.38 vs. 88.4 ± 5.53, p < 0.0001). Conclusions: Quantitative IVUS analyses display significant
catheter type-dependent variability. It is unclear whether the variability reflects overestimation of mea-
surements with the phased-array or underestimation with the mechanical system. Although plaque
burden measurements did not differ significantly between systems, it appears prudent to recommend the
use of a single system for progression/regression studies.
Introduction
Intravascular ultrasound (IVUS) allows a high
resolution tomographic assessment of the coro-
nary artery and provides accurate measurements
of both lumen and vessel wall dimensions. Ini-
tially used in interventional cardiology for diag-
nostic and interventional procedures, IVUS has
more recently been used as a tool to assess ath-
erosclerosis progression/regression in single and
multicenter studies, given its ability to accurately
quantify the presence and extent of plaque for-
mation [1–3]. In addition, plaque characterization
using gray-scale IVUS and the spectral analysis
of the raw radiofrequency data is subject to
intensive research [4–6]. Currently, a number of
IVUS systems are commercially available and
there is limited in vivo data regarding the agree-
ment between mechanical and phased-array
catheters although this information is valuable
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for the conductance of multicenter progression/
regression studies. Previous in vitro and in vivo
data showed significant variability between differ-
ent catheters in quantitative and tissue character-
ization data [7–9]. The purpose of this study was to
compare in vivo the quantitative coronary ultra-
sound measurements and plaque characterization
with mechanical and phased-array catheters.
Materials and methods
Patient population
Patients were eligible if they had a de novo, non-
significant (angiographically <50%) stenosis in a
native coronary artery. Patients were excluded
from the study if any of the following conditions
were present: (1) presentation with acute coronary
syndrome, (2) vessel tortuosity (3) calcified vessels.
The institutional ethics committee approved the
study protocol and written informed consent was
obtained from all patients.
IVUS imaging systems
Two commercially available systems were used: a
single-element, 40 MHz rotating transducer (3.2 F
Atlantis, Boston Scientific Corp.), and a 20 MHz
phased-array catheter (2.9 F Eagle Eye, Volcano
Therapeutics, Rancho Cordova, California).
Vessel interrogation
IVUS was performed after intracoronary admin-
istration of nitrates. Cine runs, before and during
contrast injection, were performed to define the
position of the IVUS catheter ‡10 mm distal to a
clear anatomical landmark. Using an automated
pullback device, the transducer of the phased array
catheter was withdrawn at a continuous speed of
0.5 mm/s until the ostium of the study vessel was
seen. Subsequently, the same procedure was per-
formed with the other IVUS imaging catheter
using a different automated pullback device (Bos-
ton Scientific Corp, Santa Clara, USA) at the same
speed. IVUS data was stored on S-VHS videotape.
The videotapes were digitized on a computer
system, transformed into the DICOM medical
image standard and stored on an IVUS Picture
Archiving and Communications System (PACS).
IVUS analysis
Quantitative coronary ultrasound (QCU) analysis
was performed by a core laboratory (Cardialysis
BV, Rotterdam, The Netherlands) using validated
software (Curad, version 3.1, Wijk bij Duurstede,
The Netherlands). IVUS analysts were not aware
of the purpose of the study. The regions of interest
(ROI) were matched simultaneously for the two
systems and selected by an independent observer
who did not participate in the contour detection
and subsequent analysis. The borders of the
external elastic membrane (EEM) and the lumen–
intima interface were determined with manual
planimetry and enclosed a volume that was defined
as the coronary plaque plus media volume. Lumen
(LCSA), vessel (VCSA), and plaque (PCSA) cross
sectional areas (CSA) were evaluated. Plaque CSA
was calculated as:
PCSA ¼ Vesselarea  Lumenarea
IVUS tissue characterization
In addition to volumetric parameters, IVUS also
provides information on plaque echogenicity, a
potential source of information on plaque com-
position. The acoustic characterization of a coro-
nary plaque has been investigated by in vitro and
in vivo studies that support a role for echogenicity
as a predictor of histological plaque composition
[1, 6, 10–12]. In the present study, we used a
computer-aided grey scale value analysis program
for plaque characterization [13]. Using the mean
grey level of the adventitia as a threshold, five
main tissue types can be characterized (Figure 3):
(1) hypoechogenic tissue has a mean grey level
lower than that of the adventitia, (2) hyperecho-
genic tissue, defined as tissue with a mean grey
value higher than that of the adventitia, (3) calci-
fied tissue, defined as a tissue with a mean grey
value higher than that of the adventitia with
associated acoustic shadowing, (4) unknown
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tissue, defined as tissue shadowed by calcification
and (5) ‘upper tissue’, defined as tissue that has a
mean grey value higher than the mean adventitial
intensity plus two times its standard deviation
but is not typical calcified tissue with acoustic
shadowing. The percentage of hypoechogenic
plaque was calculated for the entire ROI, exclud-
ing ‘upper tissue’.
Statistical analysis
Results are reported as mean ± standard devia-
tion. Bland–Altman plots were constructed in
order to assess the agreement between measure-
ments with both types of catheter [14]. This
method plots the mean against the difference in
measurements between catheters. Limits of agree-
ment were set by adding two SDs to the mean
difference for the upper limit and by substracting
two SDs from the mean difference for the lower
limit. A p value of less than 0.05 indicated statis-
tical significance.
Results
Sixteen patients were included in the analysis.
The mean age was 64 ± 9 years (range 49–82),
9 patients (56.3%) were males. The study vessel
location was RCA 4 (25%), LCX 5 (31%) and
LAD 7 (44%). Table 1 shows CSA measurements
with the two systems. Lumen (7.3 ± 2.0 mm2 vs
6.7 ± 1.8 mm2, p = 0.001) and vessel
(11.8 ± 3.3 mm2 vs. 11.0 ± 2.9 mm2, p = 0.02)
CSAs were significantly larger with the 20 MHz.
PCSA measurements showed no significant
difference between systems (4.4 ± 2.3 mm2 vs
4.4 ± 2.1, p = NS). The relative differences were
less than 10% for the 3 variables. Bland–Altman
plots for LCSA, VCSA and PCSA are shown in
Figure 1 (a, b, c).
Tissue characterization
Paired tissue characterization data was available
for 13 patients. The percent hypoechogenic vol-
ume was significantly higher with the 20 MHz
system (96.7 ± 2.38 vs. 88.4 ± 5.53, p<0.0001).
Figure 2 shows the systematic difference between
both systems.
Discussion
IVUS is currently been employed as a tool to assess
atherosclerosis progression/regression in longitu-
dinal studies [6, 15–17]. As the impact of drug
therapies on the atherosclerotic plaque burden over
time is relatively small, highly reproducible IVUS
measurements are essential. A number of IVUS
systems are commercially available and the
potential impact of inter-catheter variability, in this
setting, has not been extensively studied. Mechan-
ical and phased-array catheters have relative
advantages and disadvantages. Mechanical cathe-
ters have higher resolution but display specific
artifacts such as non-uniform rotational distortion.
In addition, far field imaging can be more prob-
lematic with mechanical catheters due to amplified
attenuation and enhanced blood backscatter. On
the other hand, phased-array catheters have lower
resolution resulting in inferior near-field imaging
and as they are not pulled-back within a sheath, are
more susceptible to non-uniform pullback speed
particularly in tortuous vessels.
Three studies explored the variability between
such systems and results were not determinant [7,
18, 19].
In an in vitro study conducted by Schoenhagen
et al., two mechanical and two phased-array cath-
eters were compared. The largest difference in
measurements compared to a phantom model was
found with a 30 MHz mechanical catheter [18]. In
the study of Hiro et al., the phased array system
Table 1. Cross-sectional area measurements for two different
IVUS imaging catheter systems (n:16).
Length LCSA VCSA PCSA
20 MHz 37.1 ± 16.8 7.3 ± 2.0 11.8 ± 3.3 4.4 ± 2.3
40 MHz 35.7 ± 15.7 6.7 ± 1.8 11.0 ± 2.9 4.4 ± 2.1
Absolute D 1.4 ± 2.2 0.6 ± 0.7 0.7 ± 0.9 0.1 ± 0.4
Relative D 3.0 ± 5.8 9.3 ± 8.7 5.9 ± 6.7 )1.4 ± 13.4
p value 0.023 0.001 0.005 NS
LCSA, VCSA and PCSA refer to lumen, vessel and plaque
cross-sectional areas.
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showed a tendency towards a higher correlation
with histology in comparison tomechanical systems
[8].
The present in vivo study shows a slight sys-
tematic difference in lumen and vessel area mea-
surements between the 20 MHz and the 40 MHz
catheters. These results are consistent with previ-
ously reported in vivo data [19] . It remains unclear
whether such variability is caused by an overesti-
mation of measurements with the phased-array
system, or by an underestimation by the mechan-
ical system. It is noteworthy, yet expected, that
measurements in vessels with mild disease were
subject to greater variability (Figure 1a).
Plaque burden measurements, a key endpoint
for atherosclerosis progression/regression trials,
showed no difference between the two systems [16].
Similar results have been shown between different
mechanical catheters[9]. Notwithstanding, the
variability shown in direct measurements, albeit
low (<10%), is not insignificant when taking into
Figure 1. (a) Bland–Altman plot where the X axis shows the
mean lumen cross sectional area (LCSA, mm2), and the Y axis
shows the difference between the LCSA measurements by 20
and 40 MHz. Thin discontinuous lines show limits of agree-
ment (upper limit 1.95 mm2 and lower limit )0.65 mm2). (b)
Bland–Altman plot where the X axis shows the mean vessel
cross sectional area (VCSA, mm2), and the Y axis shows the
difference between the VCSA measurements by 20 and
40 MHz. Thin discontinuous lines show limits of agreement
(upper limit 2.42 mm2 and lower limit )1.0 mm2). (c) Bland–
Altman plot where the X axis shows the mean plaque cross
sectional area (PCSA, mm2), and the Y axis shows the differ-
ence between the PCSA measurements by 20 and 40 MHz. Thin
discontinuous lines show limits of agreement (upper limit
1.0 mm2 and lower limit )0.88 mm2).
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Figure 2. This plot shows the individual (n:13) hypoechogenic
volume (%) for the two systems. The percentage hypoechogenic
volume was significantly and systematically higher in the
20 MHz system (96.7 ± 2.38 vs. 88.4 ± 5.53, p < 0.0001).
50
Figure 3. Cross-sectional and longitudinal views of a matched region of interest with 40 (a) and 20 (b) MHz. The adventitia is defined
as tissue outside the external elastic membrane. For all non-shadowed adventitia pixels, the mean value and standard deviation are
calculated. To observe the suitability, a normal distribution curve based on the same mean and standard deviation histogram is
created. Hypoechogenic areas are colored red (dark circle) and hyperechogenic areas green (lighter spots).
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account the relatively small changes observed with
drug therapies on plaque burden over time and
therefore might contribute to a misinterpretation
of their real biological effects.
Our results confirm that the precision required
for accurate assessment of modest drug effects
could be compromised when different IVUS sys-
tems are used in a single study.
Furthermore, the differences shown between
catheters are comparable to those previously
shown on intra and inter-observer variability [20].
We thus believe that the use of the same IVUS
system for longitudinal assessments should be
encouraged in order to achieve optimal quality
standards [21].
However, the use of a single IVUS system for
the conduction of multicenter studies is not easy in
practice and it has been previously established that
calibration equation methods can correct for dif-
ferences between catheters.
In line with the morphometric measurements,
tissue characterization data with the 20 MHz
catheter showed systematically higher hypoecho-
genic volumes and percentages. It is well known
that mechanical catheters have increased acoustic
power since they send all the energy in the same
direction. Conversely, phased-array catheters send
the energy in multiple directions, attenuating their
acoustic power. Accordingly, this could potentially
be the source for such difference.
Conclusions
In this in vivo study where we evaluated the
agreement between two different catheter designs,
plaque burden measurements, a key endpoint for
atherosclerosis progression/regression trials,
showed no difference between the two systems.
However, a significant and systematic variability
was detected in direct measurements. Tissue
characterization yielded a similar systematic dif-
ference between catheters.
It remains unclear whether the difference is
caused by an overestimation of measurements with
the phased-array system, or by an underestimation
by the mechanical system. Nevertheless, until this
issue is further explored, we consider that the use
of a single IVUS system should be recommended
for serial studies.
Limitations
The number of patients included in this study was
small. However, the conductance of large in vivo
studies of this type is difficult due to obvious eth-
ical issues. The relatively small amount of plaque
in some patients influenced the results as clearly
shown in the Bland–Altman plots. Finally, the
present study data was processed as analog (video
tape). Digital processing could have improved the
results. However, we chose the former processing
since it is the most commonly used.
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